BOSTON--(BUSINESS WIRE)--Jan. 7, 2019-- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2018 before the US financial markets open on February 4, 2019. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast at 8:00 a.m. Eastern Time (ET).
To participate in this conference call, dial 866-762-3111 (USA) or 210-874-7712 (International), conference ID 5972194 shortly before 8:00 a.m. ET. The audio webcast can be accessed on the Investor page of http://ir.alexion.com and an archived version will be available for a limited time following the presentation.
[ALXN-G]
View source version on businesswire.com: https://www.businesswire.com/news/home/20190107005228/en/
Source: Alexion Pharmaceuticals, Inc.
Investors
Susan Altschuller, Ph.D.
Vice President, Investor Relations
(475) 230-3534